Endocrine toxicity of cancer immunotherapy: clinical challenges

por Anderson, Bliss, Morganstein, Daniel L
Publicado 2021

Immunotherapy-induced endocrinopathies: assessment, management and monitoring

por Nogueira, Edson, Newsom-Davis, Tom, Morganstein, Daniel L.
Publicado 2019

Resolution of severe hyponatraemia is associated with improved survival in patients with cancer

por Balachandran, Kirsty, Okines, Alicia, Gunapala, Ranga, Morganstein, Daniel, Popat, Sanjay
Publicado 2015

Diagnostic criteria and proposed management of immune-related endocrinopathies following immune checkpoint inhibitor therapy for cancer

por Percik, Ruth, Criseno, Sherwin, Adam, Safwaan, Young, Kate, Morganstein, Daniel L
Publicado 2023

UK recommendations for SDHA germline genetic testing and surveillance in clinical practice

por Hanson, Helen, Durkie, Miranda, Lalloo, Fiona, Izatt, Louise, McVeigh, Terri P, Cook, Jackie A, Brewer, Carole, Drummond, James, Butler, Samantha, Cranston, Treena, Casey, Ruth, Tan, Tricia, Morganstein, Daniel, Eccles, Diana M, Tischkowitz, Marc, Turnbull, Clare, Woodward, Emma Roisin, Maher, Eamonn R
Publicado 2023

Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours

por Young, Kate, Lawlor, Rita T, Ragulan, Chanthirika, Patil, Yatish, Mafficini, Andrea, Bersani, Samantha, Antonello, Davide, Mansfield, David, Cingarlini, Sara, Landoni, Luca, Pea, Antonio, Luchini, Claudio, Piredda, Liliana, Kannan, Nagarajan, Nyamundanda, Gift, Morganstein, Daniel, Chau, Ian, Wiedenmann, Bertram, Milella, Michele, Melcher, Alan, Cunningham, David, Starling, Naureen, Scarpa, Aldo, Sadanandam, Anguraj
Publicado 2021